u/ingrid_correia

Glucose-dependent insulin secretion is why hypoglycaemia risk is low as monotherapy: the effect scales with glycaemia rather than acting unconditionally.

the peripheral and central stories are not in competition

Week 78 was the first time the scale moved after a five-week stall. I changed nothing in that window.

Storage guidance that names a temperature, a state and a duration reflects actual stability work.

britt_zamora is right that a purity figure without a method is not comparable to one with a method.

Asked TFC which lines they keep in regional stock versus make to order and got a clear split. It changed what I ordered.

That is a sensor value, not a plasma value, and the two are not interchangeable at that level of precision.

GLP-1 receptor agonism acts both peripherally — insulin secretion in a glucose-dependent way, slowed gastric emptying — and centrally, on appetite regulation. The central component is the better explanation for sustained intake reduction.

Was completely wrong about the gastric emptying story in a thread here two years ago. Someone corrected me with a citation and I have not made that mistake since.

Correction to my own post above — I said 10mg and I have been on 2.5mg since the spring. Same argument, wrong number.

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

zepbound and mounjaro are the same compound with different labels

pharmacy margins are regulated differently in each country

Agreed — and normalising pack size before comparing prices is the fix for half these threads.

the trials titrated on a calendar, real people titrate on symptoms

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

GIP receptor biology is genuinely unsettled — there is a live argument about agonism versus antagonism at the receptor — and the clinical results are robust regardless, which is an uncomfortable and interesting position.

net peptide content is where the surprises live

Do muscle cramps follow the day after the shot, or is it spread across the week?

This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.

a lot of people plateau nicely at 10mg and never need 15

What else is in the regimen?

the nausea profile is genuinely gentler than people expect coming from sema

The incretin effect is the observation that oral glucose provokes a larger insulin response than intravenous glucose at matched glycaemia, and the dif

isabela_nilsen is right that mechanism gives direction and not magnitude. Worth pinning.

Left up, flair changed to Discussion.

Saving this one. It is the clearest statement of the stall problem I have read here.

Which member state?

Correction to my own post above — I said 12.5mg and I have been on 10mg since the spring. Same argument, wrong number.

A1c reflects average glycaemia over roughly the preceding three months, weighted towards the most recent weeks. It cannot show variability and it lags any change you make.

That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.

Careful — that is a claim about efficacy and there is essentially no human evidence behind it.

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your food noise pattern is a guess.